Column: Why there cannot be a complete cure for cancer – but there is certainly another way!

"Is there a new way we need to be thinking about how to prevent cancer?" Lucy Robertshaw reflects upon which is the smartest way to beat cancer.

Krönika: Collaboration across borders

Coronapandemin påskyndade utveckling av cancervaccin

Coronapandemin gav ett stort uppsving för vaccinfältet. Det vittnar danska biotechbolaget Expres2ion Biotechnologies om, som utvecklar ett vaccin mot bröstcancer.

Swedish and Danish Life Science – are there still untapped synergies?

With the increasing developments in life sciences over the past decade and strong support for the sector’s strategic importance from both the Sweden and Danish ...

Smartcella värvar från Millipore Sigma

Biotech- och medtechbolaget Smartcella har utsett Nina Bauer till ny Chief Business Officer och Head of Smartwise.

Toppnamn till Smartcellas styrelse

KI-professorn Anna Martling och Regina Fritsche-Danielson, vetenskaplig ledare för Astra Zenecas forskningsanläggning i Göteborg, tar bägge plats i biotech- och...

From spin-off to phase II

”The people there will basically become your new colleagues” – Carina Schmidt, former CEO of Athera, about working with different contractors.

Marie Gårdmark: Do EMA and FDA talk to each other?

Of course they do! The collaboration started already in 2003, writes Marie Gårdmark in a column.

Skånskt bolag siktar på att bli ledande inom mitokondriell medicin

Abliva är ett av få bolag som utvecklar läkemedel mot primär mitokondriell sjukdom. Life Science Sweden besökte bolaget i Medicon Village lokaler i Lund.

Column: "Are we already living in the new normal?"

2020 felt like the year that we were building the house around us whilst moving into it at the same time.

Brexit looking back and looking forward

More than 3 years have passed after the vote and there is still uncertainty around the outcome although the UK December 12 election set a clearer course towards...

Han är ny på Sahlgrenska Science Park

Mats Hellström är Sahlgrenska Science Parks nya Lab Manager. I hans nya roll ska han se över satsningen Health Innovation Labs.

Engage with your CMO early

Gordon Hutton is Materials Science Lead at Thermo Fisher Scientific’s, formerly GSK, small molecule API site in Cork, Ireland.

Combining two drug delivery strategies to improve bioavailability

Danish researchers hope to increase the bioavailability of low solubility drugs.

Why the world renown researcher Marc Tessier-Lavigne resigns as Stanford´s president

In mid-summer, neuroscientist Marc Tessier-Lavigne announced his resignation as President of Stanford following allegations of manipulated study data. According...

Pfizer drar tillbaka omtalat läkemedel efter koppling till dödsfall

Pfizer drar omedelbart in sitt läkemedel Oxbryta mot sicklecellssjukdom på alla marknader. Orsaken är man upptäckt en misstänkt koppling till förhöjd risk för k...

Swedish Healthtech Company 1928 Pushing Forward

The full service analytics platform is expanding the business.

Marie Gårdmark: ”The situation is not satisfactory”

”The legislative tool-box is limited, but carrots in the form of longer exclusivity has already proven successful, this has for example increased registration o...

Lundabolag får brittiskt miljonbidrag för blodtest

Lundabolaget Prolight Diagnostics har fått ett statligt brittiskt bidrag på 17 miljoner kronor för fortsatt utveckling av ett blodtest som ska upptäcka eller ut...

Pharma-on-Demand

Make or buy? That is the question that the pharma world has been asking more and more in the last couple of decades. Pernille Hemmingsen is moderator at Pharma ...

Before you choose a CRO

– We are a small company and it is very important for us to maintain our core competence within development of novel nanomaterials, Tove Sivik Sonne, Head of De...

Årets opinionsartiklar 2023

Nu lider 2023 mot sitt slut. Här är några av krönikorna, debattartiklarna och ledarna från det gångna året från Life Science Sweden och systertidningarna Medtec...

Drug development creates new challenges for regulators

Helena Strigård: The rise of the community

Sweden Bio´s CEO is looking back at the last decade of development in the industry. Something has shifted in the interdependence between small and larger companies.